Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05483465 · ClinicalTrials.gov registry record · Phase 4

The Effect of NAD Supplementation on Brain Vascular Health in Aging

A Phase 4 study of Aging, sponsored by University of Oklahoma.

Recruiting
Registry status
Phase 4
Development phase
214
Enrollment target
1
Study location

NCT05483465 is a Phase 4 study of Aging that is actively recruiting participants, run by University of Oklahoma. The registered enrollment target is 214 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05483465, a Phase 4 study of Aging, is actively recruiting participants, sponsored by University of Oklahoma.

RECRUITING
Registry status
Phase 4
Development phase
214 participants
Enrollment target
1
Study location

Study Summary

Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to test whether NR can also improve brain health and memory.

Conditions Studied

Aging

Interventions

  • DRUG Placebo
  • DRUG Nicotinamide riboside

Study Locations (1)

Oklahoma

  • University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 214 participants
Start Date 2023-05-03
Est. Completion 2027-12
Phase Phase 4

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05483465

The ClinicalTrials.gov registry entry for NCT05483465 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 214 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (90% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05483465 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT05483465 about?

NCT05483465 is a clinical study titled "The Effect of NAD Supplementation on Brain Vascular Health in Aging". Daily consumption of one of the forms of Vitamin B3, the Nicotinamide Riboside (NR), energizes the body and combats cellular aging. This study is designed to test whether NR can also improve brain health and memory.

What is the current status of trial NCT05483465?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 214 participants. The study started on 2023-05-03. Estimated completion is 2027-12.

What conditions does trial NCT05483465 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT05483465?

The interventions under investigation include: Placebo (DRUG), Nicotinamide riboside (DRUG).

Who is sponsoring clinical trial NCT05483465?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05483465 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Aging

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.